Open AccessImiquimod (Aldara™ cream)
Author(s) -
Buck H.W.
Publication year - 1998
Publication title -
infectious diseases in obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.656
H-Index - 48
eISSN - 1098-0997
pISSN - 1064-7449
DOI - 10.1002/(sici)1098-0997(1998)6:2<49::aid-idog3>3.0.co;2-2
Subject(s) - imiquimod , citation , library science , medicine , health science , family medicine , dermatology , medical education , computer science
IMIQUIMOD CREAM: INDICATION Imiquimod (AldaraTM, 3M Pharmaceuticals, St. Paul, MN) is an immune-response modifier. In the United States, it is currently indicated for the treatment of external anogenital warts. Available in a 5% cream, it is applied by the patient to the warts and adjacent skin three times a week (e.g., Monday, Wednesday, and Friday or Tuesday, Thursday, and Saturday) for up to 16 weeks until warts are gone.